Usage: Alprazolam orally disintegrating tablets are indicated for the treatment of generalized anxiety disorder and panic disorder (with or without agoraphobia). Its efficacy is supported by short-term studies, with treatment duration recommendations ranging from 4 to 10 weeks for panic disorder and up to 4 months for generalized anxiety disorder.
Usage: Buprenorphine hydrochloride injection is indicated for managing severe pain requiring opioid analgesics when other treatments are inadequate. It should be reserved for patients where alternative options are ineffective or not tolerated due to risks of addiction, abuse, misuse, and overdose.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in specific patients who cannot use alternative therapies. Its use should be periodically re-evaluated due to a potential association with malignancy.
Usage: DELESTROGEN (estradiol valerate injection) is indicated for treating moderate to severe menopausal symptoms, vulvar and vaginal atrophy, hypoestrogenism from hypogonadism, castration, or primary ovarian failure, and for palliative care in advanced androgen-dependent prostate cancer.
Usage: Dexmedetomidine hydrochloride injection is indicated for sedation in initially intubated and mechanically ventilated adult patients in intensive care, and for non-intubated adults prior to and during procedures. It may be administered via continuous infusion for up to 24 hours and does not need to be stopped before extubation.